Eli Lilly to share latest portfolio and pipeline findings in cancer research at ESMO Congress 2025
Eli Lilly and Company (NYSE: LLY) today announced that new data from across its oncology portfolio and pipeline will be presented at the European Society for Medical Oncology (ESMO) Annual Meeting,… read more.




